CI Global Investments’s Core Laboratories CLB Stock Holding History

CI Global Investments’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-7,000	Closed	-$867K	–	109
2016 Q2	$867K	Sell	7,000 -3,000	-30%	-$362K	0.02%	102
2016 Q1	$1.12M	Buy	+10,000	New	+$1.04M	0.03%	94
2015 Q2	–	Sell	-312,950	Closed	-$32.7M	–	156
2015 Q1	$32.7M	Sell	312,950 -90,050	-22%	-$9.59M	0.7%	40
2014 Q4	$48.5M	Buy	403,000 +228,000	+130%	+$29.9M	0.99%	24
2014 Q3	$25.6M	Buy	175,000 +35,000	+25%	+$5.4M	0.58%	51
2014 Q2	$23.4M	Buy	+140,000	New	+$24.9M	0.6%	50

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Emerald Acquisition Seattle, Washington $51.8B AUM

CI Global Investments's CLB Position: Q3 2016 in Review

CI Global Investments sold out of Core Laboratories (CLB) in Q3 2016, closing a stake of 7,000 shares — an estimated $867K sold.

CI Global Investments first reported a position in CLB in Q2 2014 and held it in 6 quarters. The position peaked at $48.5M in Q4 2014. 372 funds tracked by Wall St. Rank hold CLB as of Q3 2016.

CI Global Investments reported no remaining Core Laboratories position as of Q3 2016 after selling out during the quarter.
CI Global Investments sold 7,000 Core Laboratories shares in Q3 2016, an estimated $867K.
CI Global Investments first reported a position in Core Laboratories in Q2 2014 and held it in 6 quarters.
CI Global Investments's Core Laboratories position peaked at $48.5M in Q4 2014.
372 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2016.

Based on CI Global Investments's 13F filing for Q3 2016, filed 18 Nov 2016.